Filing Details
- Accession Number:
- 0001213900-24-062197
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-17 17:08:11
- Reporting Period:
- 2024-07-15
- Accepted Time:
- 2024-07-17 17:08:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1051514 | Strata Skin Sciences Inc. | SSKN | Surgical & Medical Instruments & Apparatus (3841) | 133986004 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1662817 | Accelmed Partners, L.p. | C/O Strata Skin Sciences, Inc. 5 Walnut Grove Drive, Suite 140 Horsham PA 19044 | No | No | Yes | No | |
1688653 | Ltd. Management Partners Growth Accelmed | C/O Strata Skin Sciences, Inc. 5 Walnut Grove Drive, Suite 140 Horsham PA 19044 | No | No | Yes | No | |
1688989 | Accelmed Partners (Gp), L.p. | C/O Strata Skin Sciences, Inc. 5 Walnut Grove Drive, Suite 140 Horsham PA 19044 | No | No | Yes | No | |
1688990 | Ltd (Agp) Partners Growth Accelmed | C/O Strata Skin Sciences, Inc. 5 Walnut Grove Drive, Suite 140 Horsham PA 19044 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-07-15 | 230,573 | $3.14 | 1,441,835 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,441,835 | Indirect | By: Accelmed Growth Partners (GP), L.P. |
Common Stock | 1,441,835 | Indirect | By: Accelmed Growth Partners (AGP), Ltd. |
Common Stock | 1,441,835 | Indirect | By: Accelmed Management Ltd. |
Footnotes
- Shares are held directly by Accelmed Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Partners (GP), L.P., the general partner of Accelmed Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of their pecuniary interest in the shares of common stock held by Accelmed Partners, L.P.